首页> 中文期刊> 《中国处方药 》 >氨溴索联合小剂量肝素雾化吸入治疗小儿重症肺炎疗效分析

氨溴索联合小剂量肝素雾化吸入治疗小儿重症肺炎疗效分析

             

摘要

Objective Analysis clinical results of Ambroxol inhalation combined with low-dose heparin in treatment of children with severe pneumonia. Methods Selected 94 cases of pediatric patients with severe pneumonia in our hospital as the research objects, and divided into study group and the control group, 47 cases of patients in each. The patients of the two groups were given different treatment. The hematocrit, blood viscosity and other data were detected for comparison.Results After treatment, the total efficiency of study group was 97.87%, and in the control group, the total efficiency was 63.83%(P<0.05); The patients' hematocrit and blood viscosity of study group contrast with the control group were significantly different(P<0.05).Conclusion Ambroxol combined with low-dose heparin in the treatment of severe pneumonia in children can help to improve the quality of patient care, increased hematocrit values.%目的 分析氨溴索联合小剂量肝素雾化吸入治疗小儿重症肺炎的临床效果.方法 选取2013年1月~2014年6月收治的小儿重症肺炎患儿94例作为研究对象,随机分为研究组与对照组,各47例,分别给予不同治疗措施,分析对比两组治疗效果、红细胞比容、血液粘稠度等数据情况.结果 治疗后,研究组的总有效率97.87%,对照组的总有效率为63.83%(P<0.05);研究组患儿红细胞比容以及血液粘稠度明显优于与对照组,差异均具有统计学意义(P<0.05).结论 在小儿重症肺炎疾病治疗过程中,采用氨溴索联合小剂量肝素雾化吸入进行治疗,有利于提高治疗效果.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号